Prob quiet next month or so until ethics approval for P1 IMO. Once received then could get progress updates earliest mid year I'm guessing on vectus side. Could get an Ann any time on Accugen but would expect more likely Mar/Apr as getting partnership responses from hospitals presently.
Given the tightness of register I'm staying in/building slow and steady.
Ann: Publication on Reversal of Kidney Fibrotic Damage, page-7
Add VBS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.260M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| VBS (ASX) Chart |
Day chart unavailable